top of page
  • Writer's pictureRajesh Perianayagam

Karyosoft nominated and a finalist for MIRA awards - 2023

Carmel, Indiana—March 6, 2023. We are happy to announce that Karyosoft has been nominated and selected as a finalist for the third time for 2023 TechPoint Mira Award in: 1. Product Innovation of the Year category - focuses on scientific achievements, tech R&D efforts and other trailblazing discoveries. This is the fifth nomination in a specific category.

2. Rising Entrepreneur Award recognizes exceptional non-student startup founders or operators of any age and experience who have looked outside the box, started something new and generated momentum. This is our sixth nomination in a specific category and first in the "Rising Entrepreneur Award" category.

We have been recognized for this same prestigious award in 2020 and 2022 as well. We are incredibly honored to receive this prestigious recognition and to be an integral part of Indiana's tech and life sciences community.

About MIRA awards:

Coveted TechPoint Mira Awards are awarded for achievement, discovery and innovation in technology, as well as the support and advancement of the tech community. The TechPoint Mira Awards bring us together as a community to celebrate the state’s tremendous tech success stories and amplify them to media, investors and technology buyers nationwide (

About Us

Karyosoft Inc. was founded with a mission to empower non-programming life scientists with easy-to-use software solutions for genomics data and accelerate time to market for their innovations in life sciences. We believe life scientists should spend less time managing data and more time on answering biological questions that are valuable to their organizations. Our vision is to become industry leaders in providing next generation customized software solutions that make complex genomics data analytics simple in life sciences research. Karyosoft Inc. is a genomics software start-up headquartered in Carmel, Indiana, USA. ( Please send a mail to for further information.

23 views0 comments


bottom of page